Annual Total Liabilities
$7.60 M
+$331.50 K+4.56%
December 1, 2023
Summary
- As of February 8, 2025, KPRX annual total liabilities is $7.60 million, with the most recent change of +$331.50 thousand (+4.56%) on December 1, 2023.
- During the last 3 years, KPRX annual total liabilities has risen by +$2.03 million (+36.38%).
- KPRX annual total liabilities is now -81.65% below its all-time high of $41.43 million, reached on December 31, 2014.
Performance
KPRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$8.48 M
+$766.70 K+9.94%
September 1, 2024
Summary
- As of February 8, 2025, KPRX quarterly total liabilities is $8.48 million, with the most recent change of +$766.70 thousand (+9.94%) on September 1, 2024.
- Over the past year, KPRX quarterly total liabilities has increased by +$686.80 thousand (+8.81%).
- KPRX quarterly total liabilities is now -79.53% below its all-time high of $41.43 million, reached on December 31, 2014.
Performance
KPRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
KPRX Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +4.6% | +8.8% |
3 y3 years | +36.4% | +35.8% |
5 y5 years | +42.3% | +35.8% |
KPRX Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +36.9% | at high | +52.7% |
5 y | 5-year | at high | +117.8% | at high | +195.5% |
alltime | all time | -81.7% | +122.2% | -79.5% | +1954.6% |
Kiora Pharmaceuticals Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $8.48 M(+9.9%) |
Jun 2024 | - | $7.71 M(+2.3%) |
Mar 2024 | - | $7.54 M(-0.9%) |
Dec 2023 | $7.60 M(+4.6%) | $7.60 M(-2.4%) |
Sep 2023 | - | $7.79 M(+24.8%) |
Jun 2023 | - | $6.24 M(-2.0%) |
Mar 2023 | - | $6.37 M(-12.4%) |
Dec 2022 | $7.27 M(+31.0%) | $7.27 M(+1.8%) |
Sep 2022 | - | $7.14 M(+6.6%) |
Jun 2022 | - | $6.70 M(+5.1%) |
Mar 2022 | - | $6.38 M(+14.9%) |
Dec 2021 | $5.55 M(-0.4%) | $5.55 M(-31.8%) |
Sep 2021 | - | $8.15 M(+6.5%) |
Jun 2021 | - | $7.65 M(-3.6%) |
Mar 2021 | - | $7.94 M(+42.4%) |
Dec 2020 | $5.57 M(+59.7%) | $5.57 M(+69.8%) |
Sep 2020 | - | $3.28 M(+3.6%) |
Jun 2020 | - | $3.17 M(+10.4%) |
Mar 2020 | - | $2.87 M(-17.8%) |
Dec 2019 | $3.49 M | $3.49 M(-4.5%) |
Sep 2019 | - | $3.66 M(+50.8%) |
Jun 2019 | - | $2.42 M(+1.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $2.40 M(-55.1%) |
Dec 2018 | $5.34 M(-67.1%) | $5.34 M(-3.7%) |
Sep 2018 | - | $5.55 M(+0.6%) |
Jun 2018 | - | $5.52 M(-6.3%) |
Mar 2018 | - | $5.89 M(-63.7%) |
Dec 2017 | $16.23 M(+61.4%) | $16.23 M(+5.5%) |
Sep 2017 | - | $15.38 M(+11.9%) |
Jun 2017 | - | $13.74 M(+4.5%) |
Mar 2017 | - | $13.15 M(+30.7%) |
Dec 2016 | $10.06 M(+194.1%) | $10.06 M(+36.5%) |
Sep 2016 | - | $7.37 M(+16.7%) |
Jun 2016 | - | $6.32 M(+11.8%) |
Mar 2016 | - | $5.65 M(+65.2%) |
Dec 2015 | $3.42 M(-91.7%) | $3.42 M(+142.8%) |
Sep 2015 | - | $1.41 M(+119.2%) |
Jun 2015 | - | $642.60 K(+55.7%) |
Mar 2015 | - | $412.70 K(-99.0%) |
Dec 2014 | $41.43 M(+6.3%) | $41.43 M(+0.4%) |
Sep 2014 | - | $41.25 M(-0.0%) |
Jun 2014 | - | $41.25 M(+3.9%) |
Mar 2014 | - | $39.70 M(+1.8%) |
Dec 2013 | $38.98 M(+4.9%) | $38.98 M |
Dec 2012 | $37.16 M | - |
FAQ
- What is Kiora Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals annual total liabilities year-on-year change?
- What is Kiora Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals quarterly total liabilities year-on-year change?
What is Kiora Pharmaceuticals annual total liabilities?
The current annual total liabilities of KPRX is $7.60 M
What is the all time high annual total liabilities for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high annual total liabilities is $41.43 M
What is Kiora Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, KPRX annual total liabilities has changed by +$331.50 K (+4.56%)
What is Kiora Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of KPRX is $8.48 M
What is the all time high quarterly total liabilities for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high quarterly total liabilities is $41.43 M
What is Kiora Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, KPRX quarterly total liabilities has changed by +$686.80 K (+8.81%)